baber/WOPTO huggingface dataset:
Patent JP-3238814-B2 (JP)
IPC: B65B55/02
Filed: 1993-12-21
Granted: 2001-12-17
Abstract: The invention provides a method for reducing or eliminating the odors commonly produced by the sterilization of polyolefin-based products by gamma radiation. In addition, the invention also provides a method for minimizing the amount of fabric strength loss associated with the irradiation process and a method for actually increasing the fabric strength of a polyethylene that has been irradiated. Both the reduction in odors and the minimization of strength or increase in polyolefin strength are achieved in methods comprising the use of an oxygen scavenger. The invention further includes the use of non-gamma stabilized polyolefins. The polyolefinic product may also include an odor mask that may be used to mask any residual odor. <IMAGE>
Patent JP-3822339-B2 (JP)
IPC: C09K13/04
Filed: 1997-11-26
Granted: 2006-09-20
Abstract: A chemical mechanical polishing precursor composition comprising at least one catalyst having multiple oxidation states, and at least one stabilizer, the composition being useful when admixed with an oxidizing agent prior to use to remove metal layers from a substrate. Also disclosed is a chemical mechanical polishing composition comprising an oxidizing agent and at least one catalyst having multiple oxidation sites, the composition being useful when combined with an abrasive or an abrasive pad to remove metal layers from a substrate.
Patent JP-2979939-B2 (JP)
IPC: H02J7/10
Filed: 1993-12-27
Granted: 1999-11-22
Abstract: The present invention provides a distributed secondary battery type power storage system capable of maintaining the soundness of the secondary battery and of efficient electric power charging and discharging operations. The secondary battery power storage system comprises a secondary battery connected to a load, a charge/discharge unit connectable to a power system and connected to the secondary battery, and a plurality of loads connected to the charge/discharge unit. A power receiving object is selected and a capacity is determined on the basis of information about the operating condition of the plurality of loads, and the surplus electric power remaining in the secondary battery after feeding electric power from the secondary battery to the load is fed to the selected power receiving object through the charge/discharge unit. The secondary battery power storage system is capable of maintaining the soundness of the secondary battery and of efficient charging and discharging operation. <IMAGE>
Patent JP-2800850-B2 (JP)
IPC: C12Q1/68
Filed: 1993-07-20
Granted: 1998-09-21
Abstract: PCT No. PCT/GB93/01520 Sec. 371 Date Apr. 7, 1995 Sec. 102(e) Date Apr. 7, 1995 PCT Filed Jul. 20, 1993 PCT Pub. No. WO94/02633 PCT Pub. Date Feb. 3, 1994There is marked over-expression of multiple spliced variants of the CD44 gene in tumor compared to counterpart normal tissue. This observation forms the basis of a method of diagnosing neoplasia by analysis of a sample of body tissue or body fluid or waste product. A new exon 6 of 129 bp has been located and sequenced, and is claimed as such and for use in a diagnostic method.
Patent JP-2693197-B2 (JP)
IPC: F02B75/32
Filed: 1988-05-03
Granted: 1997-12-24
Abstract: In a prime mover, particularly an internal combustion engine with a minimum of one cylinder and a piston axially displaceable in the latter, which piston is connected to the crankshaft via an upper connecting rod section and a lower connecting rod section connected to the latter by an articulated joint and in which both connecting rod sections are supported by a pivoted common rocking lever on an adjustable shaft fixed to the engine housing, in order to promote increases in performance and for adaptation to different types of fuel,the upper connecting rod section (5) has, at the end remote from the piston (2), an axial extension (27) extended beyond the common articulated joint (9) of the two connecting rod sections (5, 10) and the rocking lever (14) engages in an articulated manner on the extension (27) by the end (14'') facing the connecting rod sections (5, 10). 
<IMAGE>
Patent JP-H0663531-B2 (JP)
Inventor: POTUCEK FRANK R
IPC: F16B15/08
Filed: 1989-04-12
Abstract: A star shaped fastener having at least three fins radiating from a central core with the fin-included angle in a five finned embodiment being between 72 to 98 degrees which configuration reduces the fabricated material by 50% and increases the surface area by 15%-85% compared to a common round nail of equal radius.
Patent JP-2870665-B2 (JP)
IPC: G01N1/00
Filed: 1995-07-21
Granted: 1999-03-17
Abstract: The present invention provides for a method of introducing a fluid, the method comprising the steps of: providing a first fluid conveying conduit (36) and a second fluid conveying conduit (38) substantially surrounding the first fluid conveying conduit (36) and a detector (16) operatively associated with the first fluid conveying conduit (36) and the second fluid conveying conduit (38); flowing a first fluid through the first fluid conveying conduit (36) toward the detector (16); flowing a second fluid through the second fluid conveying conduit (38) toward the detector (16); fluidly focusing the first fluid and the second fluid on the detector (16); and temporally separating flow of the first fluid and flow of the second fluid. <IMAGE>
Patent JP-4143118-B2 (JP)
IPC: A61K31/70
Filed: 1993-02-23
Granted: 2008-09-03
Abstract: Method and composition useful for treating a patient having a disease characterized by an abnormal level of one or more components, the activity of which is regulated or affected by activity of one or more inorganic-ion receptor. Novel compounds useful in these methods and compositions are also provided. The method includes administering to the patient a therapeutically effective amount of a molecule active at one or more inorganic-ion receptors as an agent or antagonist. Preferably, the molecule is able to act as either a selective agonist or antagonist at a Ca<2+> receptor of one or more but not all cells chosen from the group consisting of parathyroid cells, bone osteoclasts, juxtaglomerular kidney cells, proximal tubule kidney cells, distal tubule kidney cell, cell of the thick ascending limb of Henle's loop and/or collecting duct, keratinocyte in the epidermis, parafollicular cell in the thyroid (C-cells), intestinal cell, trophoblast in the placenta, platelet, vascular smooth muscle cell, cardiac atrial cell, gastrin and glucagon secreting cells, kidney mesangial cell and mammary cell.
Patent JP-4890666-B2 (JP)
IPC: A61P35/00
Filed: 1997-08-15
Granted: 2012-03-07
Abstract: This invention provides a method for reversing the cancerous phenotype of a cancer cell by introducing a nucleic acid having the melanoma differentiation associated gene ( mda-7 ) into the cell under conditions that permit the expression of the gene so as to thereby reverse the cancerous phenotype of the cell. This invention also provides a method for reversing the cancerous phenotype of a cancer cell by introducing the gene product of the above-described gene into the cancerous cell so as to thereby reverse the cancerous phenotype of the cell. This invention also provides a pharmaceutical composition having an amount of a nucleic acid having the melanoma differentiation associated gene ( mda-7 ) or the gene product of a melanoma differentiation associated gene ( mda-7 ) effective to reverse the cancerous phenotype of a cancer cell and a pharmaceutically acceptable carrier.
Patent JP-3596618-B2 (JP)
IPC: H04B1/16
Filed: 1994-07-21
Granted: 2004-12-02
Abstract: The present invention provides a method of minimizing synchronization delay in a radiotelephone system between a modular subscriber cluster communicating with a common base station, the modular subscriber cluster receiving repetitive time slots from the base station and having a plurality of frequency-agile modems, the method comprising the steps of: 
synchronizing a selected one of the modems to a selected time slot of the received time slots; 
generating a frame sync signal from said selected modem; and distributing said frame sync signal to remaining ones of the plurality of modems.
Patent JP-2899415-B2 (JP)
IPC: C07K14/815
Filed: 1994-10-06
Granted: 1999-06-02
Abstract: PCT No. PCT/FR94/01166 Sec. 371 Date Apr. 2, 1996 Sec. 102(e) Date Apr. 2, 1996 PCT Filed Oct. 6, 1994 PCT Pub. No. WO95/09869 PCT Pub. Date Apr. 13, 1995The invention relates to the compounds of formula (I) (SEQ ID NO: I:H-phe-A1-Arg-Pro-(Gly)4-Asn-Gly-Asp-Phe-Glu-Abo-Ile-Pro-Glu-Glu-A2-Leu-glu-OH(I)in which A1 and A2 are as defined in the description. Medicinal products containing the same are useful as anticoagulants.
Patent JP-3717187-B2 (JP)
IPC: F04B53/10
Filed: 1996-11-29
Granted: 2005-11-16
Abstract: PCT No. PCT/FR96/01906 Sec. 371 Date Sep. 24, 1997 Sec. 102(e) Date Sep. 24, 1997 PCT Filed Nov. 29, 1996 PCT Pub. No. WO97/19716 PCT Pub. Date Jun. 5, 1997A pump including a first portion (2) with a metering cylinder (3) containing a plunger (4), and a second portion (7) engaging the surface of the first portion (2) in which the outlet of the cylinder (3) is located, and comprising a recess (10) located opposite the cylinder for delivering a liquid. A flexible impervious membrane (8) clamped between the two portions (2, 7) comprises an opening (13) facing the cylinder (3) and a resilient circumferential ring (12) engaging the bottom of the recess (10). A disc (14) in the central area of the recess engages the membrane (8), and a duct (6) linked to the cylinder (5) and having an outlet in the same surface of the first portion (2) as the cylinder (5) is connected to a liquid discharge tubing.
Patent JP-3449419-B2 (JP)
IPC: C12Q1/68
Filed: 1996-12-20
Granted: 2003-09-22
Abstract: One aspect of the invention relates to the identification of the molecular basis of long QT syndrome. More specifically, the invention has identified that mutated KVLQT1 causes long QT syndrome. The analysis of this gene will provide an early diagnosis of subjects with long QT syndrome. The diagnostic methods comprise analyzing the nucleic acid sequence of the KVLQT1 gene of an individual to be tested and comparing them with the nucleic acid sequence of the native, non-variant gene. Alternatively, the amino acid sequence of KVLQT1 may be analyzed for mutations which cause long QT syndrome. Presymptomatic diagnosis of long QT syndrome will enable practitioners to treat this disorder using existing medical therapy. A second aspect of the invention relates to the realization that KVLQT1 coassembles with minK to form a cardiac potassium channel.; This allows one to assay for drugs which interact with this channel to identify new drugs which are useful for treating or preventing long QT.
Patent JP-4033410-B2 (JP)
IPC: B03C3/45
Filed: 1996-02-08
Granted: 2008-01-16
Abstract: An electrostatic filter for the separation of particles includes a particle charging unit arranged upstream, includes at least one corona wire for the charging of particles and a particle collector unit arranged downstream relative to it. The particle collecting unit includes two groups of plate-like elements (1, 1') arranged essentially parallel between each other and the flow direction through the device at a predetermined distance from each other, wherein a first group of elements (1) is connected to earth (3) and a second group of elements (1') is electrically insulated with reference to the device and to the first group of elements (1) and that the elements (1, 1') essentially are made of one or more non-hygroscopic polymer materials with a mass resistivity which preferably lies within the region of 1x102 OMEGAcm to 1x108 OMEGAcm. In one embodiment the elements are alternatively offset to each other in the longitudinal direction of the unit, whereby the first group of earthed elements (1) are arranged furthest away from the particle charging part and the other group of elements (1') are electrically insulated with reference to the device and to the first group of elements (1) and arranged nearer the particle charging part.
Patent JP-4097707-B2 (JP)
IPC: G02F1/1524
Filed: 1997-11-27
Granted: 2008-06-11
Abstract: A method for the preparation of nanoparticles of metal oxides containing inserted metal particles and to metal-intercalated and/or metal-encaged "inorganic fullerene-like" (hereinafter IF) structures of metal chalcogenides obtained therefrom is provided, which comprises heating a metal I material with water vapor or electron beam evaporation of said metal I material with water or another suitable solvent, in the presence of a metal II salt, and recovering the metal II-doped metal I oxide, or proceeding to subsequent sulfidization, yielding bulk quantities of metal II-intercalated or metal II-encaged IF structures of the metal I chalcogenide. The metal II salt is preferably an alkaline, alkaline earth or transition metal salt, most preferably an alkali chloride. The intercalated and/or encaged IF structures are usable as lubricants. They also form stable suspensions, e.g. in alcohol, and electrophoretic deposition from said suspensions yields thin films of the intercalated IF materials, which have a range of potential applications.
Patent JP-3192658-B2 (JP)
IPC: A61K8/22
Filed: 1997-03-21
Granted: 2001-07-30
Abstract: The present invention relates to a composition for dyeing keratinous fibers, especially human hair, which in a medium appropriate for dyeing comprises:as coupler at least one compound of formula: in which:R1 is especially hydrogen, alkyl, aryl, a heterocycle, a halogen, etc.;R2 is especially hydrogen, halogen, aryloxy, alkoxy, acyloxy, arylthio, alkylthio, heteroarylthio, heteroaryloxy, etc.;Za, Zb and Zc are independently a nitrogen atom or a carbon which carries a radical R3 or R4 whose meanings are identical to those of R1; at least one of Za, Zb and Zc is a nitrogen atom; and R3 and R4 may together form an unsubstituted or substituted aromatic ring; andat least one oxidation base.
Patent JP-4993799-B2 (JP)
IPC: G01N33/574
Filed: 1997-05-29
Granted: 2012-08-08
Abstract: Computerized analysis of 2-D gels, both carrier ampholyte (CA) and immobilized pH gradient (IPG) based, of the proteins in tissue from esophageal tumors, reveals proteins which are different in tumor and control tissue.
Patent PL-158022-B2 (PL)
Title: Wind and sea wave heat generating plant
IPC: F03B13/14
Filed: 1988-05-03
Abstract: The wind and sea-wave heat-generating plant consisting of a wind- and water-propelled rotor with vertical blades profiled like aeroplane propellers. The rotor shaft is connected with the shaft of the heating machine and has a propelling rotor with a pair of horizontal arms, their length equalling r measured from the axis of the shaft connected with them and mounted on top of a mast and the axis of the blade bearing. In the space between the lower ends of the blades and the base of the mast it is equipped with a horizontal, rotating platform with an outrigger, an orientation panel and a fixed ring placed in guides. On top of that ring rotationally mounted is the main crank ring. The length of the main crank equals r between the centre of the ring and the centre of the crank bushing, connected to the ring and placed on top of the pivot of the lower end of the blade in such a way as to keep the distance "a" between the pivot axis and the axis of the bearing for the pair of arms. The distance "a" is measured parallelly to the chord of the blade profile in the direction of its movement. The plant is also equipped with a differentiation mechanism for stabilising revolutions of the wind- and water-propelled rotor composed of a complete cylinder attached to the main crank, while the heating machine has a blade rotor with a cylinder mantle belting rigidly the blades. This rotor is coupled directly with the shaft of the wind- and water-propelled rotor placed in the cylinder of the heating machine body together with two five-groove rotors with diameters equalling half the diameter of the blade rotor and the internal diameter of its mantle, there is some clearance between them and they are coupled with the blade rotor by means of toothed wheels. The heat-generating plant is distinctive in that the maximum value of the circular cam (e) of the fixed ring (11) measured from the shaft axis (2) is smaller than the quantity (a) and amounts to...<IMAGE>
Patent ES-2323100-B2 (ES)
Title: Metodo de generacion de energia mareomotriz con el agua de los rios.
Inventor: JWO-HWU JI
IPC: E02B9/08
Filed: 2005-11-15
Granted: 2009-11-26
Abstract: Método de generación de energía mareomotriz con
el agua de los ríos. 
     Esta invención patente propone un método de
generación de energía mareomotriz  con el agua de los ríos. Los ríos
fluyen a las cuencas de energía mareomotriz  durante el periodo de
marea ascendente a fin de aumentar el nivel de agua  dentro de
dichas cuencas. A continuación el agua de las cuencas se conduce  al
mar para generar electricidad durante el periodo de marea
descendente.  De este modo, se aumenta la capacidad de generación de
energía. Este método  es superior a los métodos tradicionales con
respecto a su capacidad de  generación.
Patent ES-2396667-B2 (ES)
Title: Procedimiento y sistema de detección de la activación de la reversa en el aterrizaje de una aeronave
Inventor: ASENSIO RIVERA CESAR
IPC: G01H3/10
Filed: 2012-08-01
Granted: 2013-08-08
Abstract: La invención consiste en un sistema de captación sonoro que es capaz de detectar la activación de la reversa durante el aterrizaje de los aviones a partir de la detección e identificación de los sonidos producidos en el proceso. Así mismo, la invención incluye el procedimiento que debe seguirse con respecto a la ubicación de los sensores. La invención dotará a los aeropuertos de una herramienta con la que velar por el cumplimento de las normativas referidas a la activación de la reversa en materia de ruido y medio ambiente.
Patent ES-2538415-B2 (ES)
Title: Mecanismo del tipo articulado de morfología serial-paralela de cuatro grados de libertad para apuntar y guiar dispositivos hacia dianas distales
Inventor: SALTAREN PAZMINO ROQUE JACINTO
IPC: A61B90/11
Filed: 2013-12-19
Granted: 2015-11-03
Abstract: Sistema paralelo de cuatro grados de libertad para apuntar y guiar dispositivos hacia dianas distales.#El sistema está formado por dos mecanismos paralelos tipo SCARA, cada uno de los cuales está formado por dos brazos (2, 4) articulados entre sí por juntas rotacionales (3), y los brazos (4) articulados entre sí en correspondencia con efectores finales (5), siendo dicha articulación rotacional-esférica formada por un cojinete o rodamiento (7) y una rótula esférica (8), de manera que en correspondencia con esas articulaciones va montado un cilindro telescópico (9-11) que es hueco y en el que se introduce el dispositivo (17) que puede estar formado por un catéter, aguja quirúrgica u otro dispositivo similar, siendo accionados los brazos (2, 4) por motores (14) para que el dispositivo (17) montado en el cilindro telescópico y hueco (9-11) pueda ser guiado, desplazado y posicionado en un punto concreto de un paciente, por ejemplo, situado sobre una mesa.
Patent AU-2001275720-B2 (AU)
Title: Excess-flow valve
Inventor: OSBORNE GRAHAM WILLIAM
IPC: F16K17/36
Filed: 2001-07-27
Granted: 2005-11-17
Abstract: An automatically operating valve for use for example in a forecourt fuel pump has a body (10) defining a flow passage (20) within which is formed a valve seat (22), the body having a weakened zone (16) around the flow passage (20) such that an impact on the body will fracture the body at the weakened zone. A valve member (30) is mounted for movement within the flow passage (20) and is engageable with the valve seat (22) to close the valve. A closing mechanism effects movement of the valve member (30) to its closed position in the event that the body (10) is fractured at the weakened zone. Further, the valve member (30) is configured to move to its closed position under the influence of excessive flow of liquid through the flow passage (20).
Patent AU-2002236871-B2 (AU)
Title: Detection and quantification of CRIPTO-1
Inventor: SALOMON DAVID
IPC: G01N33/68
Filed: 2002-01-23
Granted: 2006-09-28
Abstract: The present invention provides methods and compositions for the detection and quantification of Cripto-1. In particular, the present invention provides methods and compositions for the detection and quantification of Cripto-1 in samples such as milk, plasma, serum, and other biological fluids. In particularly preferred embodiments, the present invention finds use in the detection and/or quantification of Cripto-1 in human milk, plasma, serum, and other biological fluids.
Patent AU-2002322964-B2 (AU)
Title: Dosage forms having prolonged active ingredient release
Inventor: TRUOG PETER
IPC: A61P35/02
Filed: 2002-09-04
Granted: 2008-10-16
Abstract: A pharmaceutical unit dosage form comprising a therapeuically effective dose of a 4-phenylbutyric acid salt having prolonged release of the active ingredient, being suitable for alleviating and curing various diseases upon once or twice daily oral administration, a method of preparation of said pharmaceutical formulation and the use thereof for the treatment of benign prostate hyperplasy, cancer, leukemias, cystic fibrosis, AàIDS, kidney and liver diseases, thalassemia and urea cycle disorders comprising the twice-daily oral administration of a therapeutically effective dosage thereof to a patient.
Patent AU-2002323569-B2 (AU)
Title: Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
Inventor: THEEUWES FELIX
IPC: A61K31/4468
Filed: 2002-08-29
Granted: 2008-05-29
Abstract: The invention features devices and methods for treatment of pain. The drug delivery device is a drug delivery system adapted for whole implantation in a subject and to provide pain relief by delivery of fentanyl or a fentanyl congener (e.g., sufentanil) over a protracted period of time (e.g., at least 3 days or more than 3 days). The device comprises a housing defining a reservoir that contains a drug formulation, a pump operatively connected to the housing so as to facilitate movement of drug out of the reservoir and out of the device, and a thermal expansion element which defines a flow pathway comprising a thermal expansion channel to accommodate thermal expansion of formulation in the reservoir. The device can further comprise a valve positioned within the flow pathway so as to prevent movement of drug out of the reservoir prior to use.
Patent AU-2002330656-B2 (AU)
Title: Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same
Inventor: KOMPAGNE HAJNALKA
IPC: A61K31/50
Filed: 2002-09-26
Granted: 2009-04-09
Abstract: The invention relates to substituted alkylaminopyridazinone derivatives of the general Formula (I), (wherein R<SUB>1 </SUB>is hydrogen or alkyl having 1-4 carbon atoms; one of X and Y stands for hydrogen or halogen and the other represents a group of the general Formula (II), R<SUB>2 </SUB>is hydrogen or alkyl having 1-4 carbon atoms; n is 1, 2 or 3; R<SUB>3 </SUB>stands for hydrogen, alkyl having 1-4 carbon atoms or aryl-(C<SUB>1-4 </SUB>alkyl); Z stands for oxygen; or R<SUB>3 </SUB>and Z together with the groups placed between them form a piperazine ring; and R<SUB>4 </SUB>stands for hydrogen, halogen, trifluoromethyl or alkoxy having 1-4 carbon atoms) and pharmaceutically acceptable acid addition salts thereof. The invention compounds are useful in the treatment of anxiolytic conditions and cognitive disorders.